Subjects: 131 healthy parturient mothers, with normal pregnancies and deliveries in St Joan University Hospital, and their newborn infants. Interventions: Erythrocyte haemolysates were prepared from maternal blood at delivery and infants' umbilical cord blood and used to measure micronutrient status using the transketolase, glutathione reductase and aspartate aminotransferase coenzyme stimulation tests. Results: Maternal and infant coenzyme activities were signi®cantly correlated, but infant coenzyme status was better than maternal, with signi®cantly higher basal and stimulated activity (P`0.001) and signi®cantly lower activation coef®cients (P`0.001). Inadequate thiamin, ribo¯avin or pyridoxine status occured in 38.2 ± 62.6% (50 ± 82) of the mothers and 3.1 ± 37.4% (4 ± 49) of the infants; 85.2% (46/54), 12.9% (4/31) and 24.1% (12/54) of infants born to mothers with biochemical de®ciency of either thiamin, ribo¯avin or pyridoxine, respectively also had inadequate status. Maternal de®ciencies in more than one vitamin further increased the risk of infant thiamin and pyridoxine de®ciency. Maternal and infant ribo¯avin status were signi®cantly correlated with fetal development (e.g. length at birth, P`0.001). The incidence of thiamin de®ciency in paturient mothers in Spain was the highest out of a 12-country comparison.
Introduction
The importance of maternal nutrition before and during pregnancy for the health of both the mother and infant is well established (Rosso, 1990a; Jovanovic-Peterson & Peterson, 1996; James, 1997; Godfrey & Robinson, 1998) . Pregnancy is a period of increased nutritional requirement for the mother. The enhanced physiological demand for nutrients by the mother and the extra nutrient requirements for normal fetal development can be met by dietary means or by supplementation of some nutrients when necessary (Rosso, 1990b) .
It is dif®cult to de®ne vitamin de®ciency during pregnancy because most vitamin parameters change signi®cantly during pregnancy owing to maternal physiological adaptation (Bruinse & van den Berg, 1995) . Therefore, it is dif®cult to differentiate between hypovitaminaemia caused by physiological changes and that which is further affected by, for example, insuf®cient vitamin intake by the mother. Some authors have accepted pregnancy hypovitaminaemia as a normal physiological consequence (Bruinse & van den Berg, 1995) . But inappropriate maternal dietary intake of vitamins during pregnancy has also been reported (Ortega et al, 1994; Tovar et al, 1996; Antal et al, 1997 ) which, at a time when maternal vitamin status is already vulnerable to decline, would enhance biochemical vitamin de®ciency. Maternal biochemical de®ciency of thiamin, ribo¯avin and pyridoxine during pregnancy has been reported in a number of studies in both developed and developing countries (Dosta Âlova Â & Va Âclavõ Ânkova Â, 1985; Fidanza et al, 1986; Ac Ëkurt et al, 1995; Pongpaew et al, 1995; Tovar et al, 1996) . De®ciency in some or all of these vitamins during pregnancy can adversely affect both maternal and fetal health. Aspects of fetal health that may be adversely affected are nutritional status of these vitamins and growth and development. Ortega et al (1994) have suggested the need for vitamin supplementation of Spanish pregnant women, based on their observation that thiamin and ribo¯avin intakes were lower than the recommended daily allowances (RDAs) in 12% and 23%, respectively, of the pregnant women whose dietary habits were studied. However, the diet of these women is not representative of the national average nor of the typical diet of the Mediterranean region, which has often been viewed as the`ideal' diet. Furthermore, given the margin of needs covered by RDAs, the ®nding that 12 ± 23% of a well-fed population has vitamin intake below RDAs is not a suf®ciently high percentage to merit vitamin supplementation. Vitamin de®ciency should be con®rmed biochemically and assessed in other regions of Spain before recommendation of a national basis food forti®cation or supplementation of B-group vitamins to this`high-risk' group.
The aim of this study was to determine the biochemical status of thiamin, ribo¯avin and pyridoxine in parturient mothers and their newborn infants living in a Mediterranean region of Spain and to explore the maternal ± infant vitamin status relationship.
Subjects and methods

Subjects
Reus is a city of $ 90 000 inhabitants on the Mediterranean coast of Catalonia, Spain. The study was performed on parturient mothers and their newborn infants. Only healthy mothers who had completed term pregnancies with no complications and normal deliveries, and their newborn babies, were included in the study. The mother group included 131 women aged (mean AE s.d.) 26.0 AE 5.0 years (minimum age was 16 and maximum was 41) who had just given birth in the Sant Joan University Hospital in Reus. Information was obtained from the mothers on their previous use of oral contraceptives, the length of time that they had used them, and the length of time between stopping using them and becoming pregnant. The 131 infants consisted of 70 girls and 61 boys, all of whom were normal, healthy children and none of whom were twins. Birth weight (mean AE s.d., range) was 3320 AE 360 g (2580 ± 4270); length was 49.7 AE 2.3 cm (34.5 ± 55.0); head circumference was 34.8 AE 2.4 cm (31.0 ± 49.0). Apgar test results were at 1 minute, 8.8 AE 0.9 (2.0 ± 10.0) and at 5 minutes 9.9 AE 0.4 (7.0 ± 10.0). The protocol for the study was reviewed and approved by the Sant Joan Hospital ethical committee.
Instrumentation
Beckman DU-40 spectrophotometer, UV/visible 190 ± 900 nm with water temperature control between 20 and 50 C AE 0.1 C (Beckman Instruments, CA, USA). Refrigerated centrifuge (IEC Centra-7, International Equipment, CO, USA). Centrifuge for haematocyte preparation (Immunofuge, American Dade, USA).
Blood sampling and preparation of erythrocytes Blood was sampled from the mothers at delivery by venepuncture and from the umbilical cords of the infants and was collected into tubes containing EDTA-K2 (anticoagulant). Erythrocytes were prepared by centrifuging the samples at 3000 rpm for 10 min. The plasma and buffy coat were removed and discarded and the erythrocytes were washed three times with 0.9% saline, centrifuging each time for 2 min at 800 rpm while chilling at 4 C.
Haemoglobin determination
Haemoglobin concentration was measured using Drabkin's reagent as described by Furth-Walker et al (1989) .
Enzymatic determinations
Thiamin, ribo¯avin and pyridoxine status assessment: Vitamin coenzyme activity tests provide a sensitive biochemical assessment of the functional state of the vitamin in the erythrocyte. For the assessment of status of each vitamin, erythrocyte coenzyme activity was measured before (basal activity) and after (stimulated activity) the addition of an enzyme. Dividing the stimulated activity by the basal activity gave the coenzyme activation coef®cient (AC) value. Under optimal conditions, the AC value should be close to 1.00. If the basal activity of the enzyme is reduced as a result of coenzyme de®cit, the AC value increases. Manual coenzyme stimulation assays were performed. Thiamin pyrophosphate (TPP) was added to determine erythrocyte transketolase (ETK)-stimulated activity (Smeets et al, 1971) in thiamin status determinations. Flavin ± adenine dinucleotide (FAD) was added to determine erythrocyte glutathione reductase (EGR)-stimulated activity (Beutler, 1969) in ribo¯avin status determinations. Pyrixodal 5-phosphate was added to determine erythrocyte aspartate aminotransferase (EAST)-stimulated activity (Bergmeyer et al, 1978) in pyridoxine status determinations. The criteria used to de®ne biochemical vitamin status in this study are listed in Table 1 . Cut-off points for thiamin were obtained from Benton et al (1997) , Bailey et al (1994) and Gubler (1991) ; for ribo¯avin from Benton et al (1997) , Cooperman & Lopez (1991) and Glatzle et al (1974) ; and for pyridoxine from Benton et al (1997) , Leklem (1990 Leklem ( , 1991 and Sauberlich (1972) .
Reagents:
The reagents used for ETK determinations were as described by Smeets et al (1971) . Those used for EGR determinations were as described by Beutler (1969) . Those used for EAST determinations were as follows. Aspartate aminotransferase monotest kit, (Boehringer, Mannheim) was used. The concentrations of the reagents, once redissolved in doubly distilled water are: Vial 1, TrisHCl 96 mM, pH 7.8, NADH 0.22 mM, L-aspartate 288 mM, lactate dehydrogenase ! 0.72 U/ml, malate dehydrogenase ! 0.50 U/ml; Vial 2, a-ketoglutarate 144 mM. These reagents were kept at 4 C for a maximum of 3 weeks. Pyridoxal 5-phosphate (PLP) (Sigma), 0.4 mM and 0.0099 g PLP were dissolved in 10 ml Tris-HCl buffer and stored in aliquots at 7 20 C, protected from light. Sample storage conditions: The haemolysates were kept at 7 20 C until processed. We tested storage conditions and duration and accordingly all samples were processed within 5 weeks of collection to prevent loss of basal enzyme activity.
Quality control: Quality control assays were performed for each of the ETK, EGR and EAST assays. Intra-assay and inter-assay coef®cients of variation were never in excess of 6% or 8%, respectively, for any of the coenzyme stimulation assays.
Statistical analysis:
The chi-squared test was used to test the probability of the mother's vitamin status in¯uencing that of her newborn infant by indicating the likelihood of differences between vitamin status in the two groups. The Student's paired t-test was used to compare the differences between the means of coenzyme activities between mothers and infants. The Student's unpaired t-tests was used to compare means from independent groups. To test correlation between two quantitative variables, Pearson's product moment correlation coef®cient, r, was calculated.
Results
Although the infant group consisted of girls and boys, no differentiation has been made between their results because coenzyme activity was unaffected by sex.
Previous oral contraceptive use Oral contraceptives had previously been used by 49.6% (65) of mothers. Of previous users of oral contraceptives, 47.7% (31) had used them for up to 1 year, 18.5% (12) for up to 2 years, 27.7% (18) for up to 5 years and 6.1% (4) for more than 5 years; 33.8% (22) of previous users of oral contraceptives became pregnant within 3 months, 38.5% (25) within 3 ± 12 months and 27.7% (18) within 24 ± 82 months after stopping their use. EAST basal activity was signi®cantly lower in previous oral contraceptive users than in non users (mean AE s.d.), 5.8 AE 1.4 and 7.1 AE 1.8 U/g Hb, respectively, Student's unpaired t-test, P`0.01. The length of time of previous oral contraceptive use and EAST AC were signi®cantly correlated (r 0.17; P`0.05; n 65).
Maternal and infant thiamin, ribo¯avin and pyridoxine status at birth Maternal and infant basal and stimulated activities and activation coef®cients for erythrocyte transketolase, glutathione reductase, and aspartate aminotransferase, are listed in Table 2 . The mean maternal coenzyme basal and stimulated activities were signi®cantly lower than those of the infants. Each coenzyme activation coef®cient value was signi®cantly lower in the infant group. The Pearson's correlation coef®cient values indicate that there was a signi®cant correlation between maternal and infant coenzyme activity in the case of all three vitamins.
Maternal and infant thiamin, ribo¯avin and pyridoxine biochemical status is illustrated in Figure 1 . Infant status was clearly better than maternal in the case of all three vitamins, but especially in the cases of ribo¯avin and pyridoxine. Ribo¯avin status was the best out of the three vitamins in both the mother and infant groups with 61.8% (81) and 96.9% (127), respectively, being of adequate status; 57.3% (75) of mothers and 90.1% (118) of the infants had adequate pyridoxine status. Only 37.4% (49) of mothers had adequate thiamin status compared with 62.6% (87) in the infant group. 
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Maternal thiamin and pyridoxine status were signi®-cantly correlated (r 0.19; P`0.05; n 131).
The effect of maternal vitamin status on infant vitamin status and fetal development
The effect of maternal thiamin, ribo¯avin and pyridoxine status on that of the newborn infant is shown in Table 3 . The chi-squared test showed that maternal vitamin status Figure 1 Thiamin, ribo¯avin and pyridoxine status, as determined from their respective coenzyme activation coef®cient values, in parturient mothers at birth (a) and their newborn infants (b). The de®nition of the categories adequate, marginally de®cient and de®cient is shown in Table 1 . The percentage of subjects within each category is illustrated for both groups. Criteria for vitamin status de®ned in Table 1 . Table 4 shows the biochemical status of thiamin, riboavin and pyridoxine in mothers who showed biochemical de®ciency in one or more of these vitamins. Only 38.9% (21) of mothers who were de®cient in thiamin had adequate status for ribo¯avin and pyridoxine; 19.4% (6) of mothers who were de®cient in ribo¯avin had adequate status for thiamin and pyridoxine; and 20.4% (11) of mothers who were de®cient in pyridoxine had adequate status for thiamin and ribo¯avin. Table 5 shows the effect on infant status for each individual vitamin of different combinations of status for the three vitamins in the mother. Adequate maternal status for ribo¯avin or pyridoxine, regardless of the maternal status for the other two coenzymes (R2, P2), was signi®-cantly correlated with infant status for each respective vitamin. However, the same relationship did not hold for thiamin; the data were not signi®cant for thiamin (T2). A high percentage of infants with inadequate thiamin status were born to thiamin-de®cient mothers (T4 ± T8). Infant thiamin status was more adversely affected when the mother also had inadequate status for one or both of ribo¯avin and pyridoxine (T5 ± T8). The general tendency for the protection of infant ribo¯avin status, shown in Table  3 , was maintained. Comparing the infants born to mothers who were de®cient only in ribo¯avin (R4), with those born to mothers who also had inadequate status of either or both of thiamin and pyridoxine (R5 ± R8), the resulting infant ribo¯avin status was generally unaffected by maternal thiamin or pyridoxine status. Similarly, the pyridoxine status of infants born to pyridoxine-de®cient mothers (P3, P4) was generally unaffected by maternal thiamin and ribo¯avin status unless the mother had inadequate status for both thiamin and ribo¯avin (P5, P6).
The 14 mothers who were de®cient in thiamin and pyridoxine but had adequate ribo¯avin status, and their infants, are illustrated in lines T5 and P4. The effect of this combined maternal de®ciency on infant vitamin status was clearly more severe in the case of thiamin (T5) than for pyridoxine (P4) since 12 infants had thiamin inadequacy compared to only 2 with pyridoxine de®ciency. The 8 mothers who were de®cient in thiamin and ribo¯avin but had adequate pyridoxine status, and their infants, are illustrated in lines T6 and R6. The effect of this combined maternal de®ciency on infant vitamin status was again more severe in the case of thiamin (T6) than for ribo¯avin (R6). 0.14 0.14 0.14 0.14 0.08 7 0.01 *P`0.05; **P`0.01; ***P`0.001. n (M), number of matters; n (I), number of infants.
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compared with the number of normal infants born to mothers who were de®cient only in one vitamin (T4, R4, P3). The effect of each of maternal and infant vitamin status, determined from coenzyme activity, on fetal development is illustrated in Table 6 . Pearson's correlation coef®cients, r, between maternal or infant coenzyme activities and anthropometric measurements of the infant at birth are shown. There was no signi®cant correlation between maternal ETK and EAST coenzyme activities and infant body weight, length and head circumference at birth. However, maternal and infant basal EGR activities were signi®cantly correlated with infant birth length, and both maternal and infant EGR AC values were signi®cantly inversely correlated with birth weight and length.
International comparison of thiamin, ribo¯avin and pyridoxine status Figure 2 (a) compares the incidence of biochemical vitamin de®ciencies, determined by coenzyme activation coef®-cients, in our study (Spain) with previous studies in various countries by applying the de®nition of vitamin de®ciency from each study to our subjects. The results show comparisons between parturient mothers in Spain and either parturient mothers or women in the third trimester of pregnancy in the other countries. Additional information on the international studies is included in Table 7 . All the results included in the third-trimester group were from women in at least their 35 week of pregnancy. The incidence of thiamin de®ciency in Spain in parturient mothers was similar to that in the Kenyan study and higher than in any of the studies in Europe, Thailand and India. The incidence of ribo¯avin de®ciency in parturient mothers in Spain was substantially lower than in Kenya, India, Mexico, Thailand and Turkey and similar to that in other European countries such as Northern Ireland, Italy and The Netherlands, but higher than in Switzerland (1984 and 1982) . The incidence of pyridoxine de®ciency in parturient mothers in Spain was higher than in Mexico (1987 ), Germany (1973 ) or Turkey (1995 , similar to that in Sweden (1985) , slightly lower than in Switzerland (1982 Switzerland ( ± 1985 , and substantially lower than in Thailand, Mexico (1996) and The Netherlands (1978) .
A similar comparison for infant vitamin status is illustrated in Figure 2(b) . Thiamin de®ciency in Spanish infants was similar to that in Kenya and India and higher than in Italy, Thailand and Switzerland. Ribo¯avin de®-ciency in Spanish infants was similar to that in Italy, Switzerland and Mexico and substantially lower than in Kenya, India and Thailand. Pyridoxine de®ciency in infants in Spain was higher than in Mexico, lower than in Switzerland (1982) and Sweden and similar to that in Thailand and Switzerland (1985) .
Discussion
This study assessed the functional status of thiamin, riboavin and pyridoxine in erythrocytes using coenzyme activity tests. These tests offer a long-term assessment of vitamin status and enable the detection of subclinical vitamin de®ciency (Bitsch, 1993; Brin, 1980) .
Application of coenzyme activity tests in the determination of maternal and infant vitamin status
Various guidelines that have been used to de®ne vitamin status in a population are listed in Table 8 . We chose our criteria based on the guidelines from The Handbook of Vitamins (Cooperman & Lopez, 1991; Gubler, 1991; Leklem, 1991) and the most widely used criteria in recent studies. Generally, in previous studies the same reference ranges have been used for pregnant and non-pregnant populations and for adults and infants/children. Van den Berg et al (1978) suggested that due to their immaturity, infants' cells have better apoenzyme-coenzyme binding which would affect the outcome of coenzyme activity tests and a Brubacher (1988) commented, there is a lack of guidelines that take into account the in¯uence of the increased vitamin requirement, increased plasma volume and changes in hormonal status caused by pregnancy on the outcome of vitamin status tests. However, since the activation coef®cient is a ratio of the stimulated and basal enzyme activities, it suf®ciently corrects the problem of hypovitaminaemia (Bruinse & van den Berg, 1995) of pregnancy or red cell immaturity in cord blood to enable similar guidelines to be used in their biochemical status assessment. Vudhivai et al (1990) reported infant pyridoxine status inferior to maternal in a study in Thailand, thus indicating that inadequate vitamin status could be detected in infants using coenzyme activation tests with the same reference guidelines for infant and adult vitamin status.
The results of our study support the application to parturient mothers and their infants of reference intervals for the general population. We found biochemical evidence for adequate, marginally de®cient and de®cient status in each of thiamin, ribo¯avin and pyridoxine in our study population. Furthermore, some studies have shown evidence of maternal and infant de®ciency symptoms within these reference ranges. Debuse (1992) reported Shoshin beriberi in a breast-fed infant whose mother had biochemical evidence of mild thiamin de®ciency (ETK AC: 1.18) and several studies have demonstrated the importance of adequate maternal and infant pyridoxine status, de®ned within regularly used cut-off points, for maternal health and behaviour and for growth, development and behaviour in breast-fed infants (Heiskanen et al, 1995a; Kang-Yoon et al, 1995) .
Maternal and infant thiamin status
Previous opinion on the effect of pregnancy on the ETK test is con¯icting, with Rosso (1990c) and Bamji (1976) suggesting that this test is affected by the physiological changes of pregnancy, and Bruinse & van den Berg (1995) concluding rather that the test is unaffected.
Although there was a high percentage of parturient mothers with abnormal ETK tests in this study, a number of mothers had normal results. Normality within a reference range used for non-pregnant populations suggests that either these mothers had excellent periconceptional thiamin status that overrode the physiological strains of pregnancy or that the ETK tests were simply unaffected by pregnancy.
To ®nd that 62.6% of apparently healthy parturient mothers were at risk of being of marginal or de®cient biochemical status in thiamin in a developed country like Spain seems alarming. However, Gubler (1991) highlighted the increasing incidence in developed countries of subclinical or borderline thiamin inadequacy that affects the individual's performance and well-being without showing obvious signs of de®ciency. Thiamin de®ciency in parturient mothers has been reported in other developed countries as is shown in Figure 2(a) , but surprisingly studies in countries in regions of the world where nutritional Maternal and neonatal vitamin status DJ Sa Ânchez et al problems may be expected (e.g. India, Thailand, Kenya) generally did not ®nd higher levels of thiamin de®ciency.
Although cord blood analysis indicated that infant biochemical vitamin status was better than maternal status at birth in this study, 37.4% of the newborn infants had abnormal ETK tests indicating that they were at risk of marginal or de®cient biochemical thiamin status.
Maternal and infant ribo¯avin status
The results of the EGR tests showed that maternal and infant ribo¯avin status was the best of the three vitamins examined, and was also on a par with ribo¯avin status reported in other European countries (Figures 2a,b) . It was also evident that infant ribo¯avin status was apparently protected from adverse maternal ribo¯avin status since Figure 2 (a) Comparison of the levels of de®ciencies of thiamin, ribo¯avin and pyridoxine in parturient mothers or gestants during the third trimester of pregnancy, calculated from erythrocyte coenzyme activation coef®cient (AC)`cut off' points, in the Spanish study with international studies. The country and the year of publication are shown here. Further details on the studies are given in Table 4 .
Maternal and neonatal vitamin status DJ Sa Ânchez et al 87.1% of intants born to ribo¯avin-de®cient mothers had normal status. This protection is even more important considering the relationship we found between ribo¯avin status and fetal development (Table 6 ). However 38.2% of mothers were at risk of being marginally de®cient or de®cient biochemically in ribo¯avin, which could have important implications, especially for maternal health but also for infant health.
The effect of ribo¯avin status on fetal anthropometry was in contrast to observations by Vudhivai et al (1990) , Vir et al (1981) and Heller et al (1974b) , all of whom reported that there was no correlation between ribo¯avin status and anthropometric measurements of the newborn at birth. However, Badart-Smook et al (1997) reported a positive correlation between maternal ribo¯avin intake during pregnancy and infant birth weight and length. Figure 2 (b) Comparison of the levels of de®ciencies of thiamin, ribo¯avin and pyridoxine, calculated from erythrocyte coenzyme activation coef®cient (AC)`cut off' points, in the Spanish study with international studies.
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Ac Ëkurt et al (1995) also reported an association between maternal ribo¯avin levels during early pregnancy and growth and development of 13 to 17-week-old infants.
Maternal and infant pyridoxine status
The results of the EAST tests showed that 41.2% of parturient mothers in our study were biochemically de®-cient in pyridoxine, thus putting their infants at risk of abnormal development (Guilarte, 1993) , and especially the infants who would subsequently be breast-fed (Heiskanen et al, 1995b) . It has already been shown, in a study in Egypt, that breast-feeding mothers with inadequate pyridoxine status and their infants showed behavioural abnormalities that also affected mother ± baby relationships compared to mothers and babies with adequate pyridoxine status (McCullough et al, 1990 ).
In the case of each vitamin, biochemical status of the newborn infant was better than maternal status, which has been reported previously (Bamji, 1976) . This might be expected because of placental sequestration of nutrients throughout pregnancy for the bene®t of the infants but at the expense of the mother.
The effects of maternal combined vitamin status on maternal and infant individual vitamin status Since 61.1% of thiamin-de®cient mothers were also de®-cient in either or both of ribo¯avin and pyridoxine, it is possible that the combined effect of overall inadequate status in other nutrients may have predisposed them to thiamin de®ciency. Previous studies have shown that changes in levels of other nutrients, including pyridoxine, can modify thiamin metabolism and function (Zieve, 1969; Kimura & Itokawa, 1977; Gubler, 1991) .
Maternal combined vitamin de®ciencies put the infant at a greater risk of inadequate thiamin status. It was evident that if a mother had de®cient thiamin status that there was a strong likelihood that her infant would also have inadequate thiamin status, and this likelihood was increased when the mother's ribo¯avin and pyridoxine status were also inadequate.
Although maternal ribo¯avin status was the best out of all the vitamins studied (Figure 1) , it was clear that it was the most affected out of the three vitamins by maternal inadequacy in other vitamins. The ETK and EAST tests in 80.6% of the mothers (i.e. 25 out of 31 mothers) who had biochemical evidence of de®ciency in ribo¯avin showed inadequacies in thiamin and or pyridoxine (Table 4) .
While hormonal factors may have contributed to maternal pyridoxine de®ciency, it was evident that 79.6% of mothers (i.e. 43 out of 54 mothers) who had biochemical evidence for pyridoxine de®ciency also had inadequate status in either or both of thiamin and ribo¯avin (Table  4) . Bitsch (1993) has suggested previously that ribo¯avin status might be expected to affect pyridoxine status sincē avin enzymes are involved in the interconversion of the various forms of pyridoxine.
How can vitamin de®ciency during pregnancy occur in a Mediterranean region? Previous explanations for vitamin de®ciency during pregnancy have included dietary insuf®ciency, limited intestinal ! 3.37 Schrijver et al (1985) b 1.25 b 2.20 Mount et al (1987) 1.07 ± 1.30 0.96 ± 1.68 1.46 ± 1.90 Vudhivai et al (1990) b 1.25 b 1.50 b 3.37 Leklem (1990 Leklem ( , 1991 Maternal and neonatal vitamin status DJ Sa Ânchez et al absorption, increased metabolic demands of the growing fetus, placental transfer mechanisms, impaired metabolism and haemodilution. However, despite the reduction in maternal vitamin status caused by these extra physiological demands, a normal, healthy, pregnant mother should be expected to maintain adequate vitamin status throughout pregnancy, as was seen in 37.4%, 61.8% and 57.3% of mothers for thiamin, ribo¯avin and pyridoxine status in this study. In the remaining mothers, a likely contributor to inadequate vitamin status was their diet. Given to the wide variety of food available in the Mediterranean region, which should provide an adequate dietary supply of vitamins, it is probable that inadequate dietary vitamin intake is complicated by losses during food processing and is due to traditional cooking methods rather than to the unavailability of vitamins. While cereals form an important part of the traditional diet (Wolever et al, 1991) , the norm is to use white¯our and rice, which will have lost most of their thiamin (Gubler, 1991) , ribo¯avin (Cooperman & Lopez, 1991) and pyridoxine (Leklem, 1991) content during milling. In contrast to the case in other developed countries, rice and¯our are not forti®ed with vitamins in Spain.
Another important vitamin loss occurs in the traditional addition of sodium bicarbonate, which destroys thiamin in the cooking of legumes, and in the over-cooking of vegetables in excessive quantities of water. The excessive consumption of foods containing thiaminases, e.g. coffee or shell®sh (Eijkman & Grijns, 1992) , would also predispose an individual to reduced thiamin status. The effect on pyridoxine status of previous oral contraceptives, causing reduced basal EAST activity, and of duration of previous use being signi®cantly correlated with EAST AC, is consistent with previous studies (Leklem, 1986) . Leklem (1991) also reported hormoneinduced effects on pyridoxine metabolism.
Pregnant smokers have been shown to have a lower pyridoxine status than pregnant non-smokers (van den Berg, 1988). Since we did not collect data on the number of mothers who smoked, our study would have included smokers. Therefore, smoking may have contributed to reduced pyridoxine status in up to an estimated 46% of our study population (Prieto, 1995) .
Conclusions
Vitamin de®ciencies have been found in two`high-risk' groups (parturient mothers and newborn infants) of the Reus population. Further studies are required to determine the status of ribo¯avin, pyridoxine and especially thiamin in the general population.
Maternal and infant status for all three vitamins were correlated and infant status was generally better than maternal. Maternal and infant ribo¯avin status was correlated with fetal development. Maternal thiamin and pyridoxine status were signi®cantly correlated and infant thiamin status was also affected by maternal ribo¯avin and pyridoxine status.
The vitamin status of pregnant mothers could be improved by the use of multivitamin supplements before and during pregnancy. There is no national health policy of B-group vitamin supplementation either periconceptionally or during pregnancy in Spain, and, it is unusual in clinical practice. Forti®cation of rice and¯our with vitamins, which also is not standard practice in Spain, would bene®t not only pregnant mothers but the population as a whole.
